Receptor‐selective changes in µ‐, δ‐ and κ‐opioid receptors after chronic naltrexone treatment in mice

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Neuroscience

• Publication date

  2003-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1460-9568.2003.02502.xPMID 12653976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Exploring the opioid system by gene knockout.

  2002cited by this paper
• Pharmacotherapy of addictions

  2002cited by this paper
• Regulation of μ-opioid receptors, G-protein-coupled receptor kinases and β-arrestin 2 in the rat brain after chronic opioid receptor antagonism

  2002cited by this paper
• Regulations of opioid dependence by opioid receptor types.

  2001cited by this paper
• Regional expression of a gene encoding a neuron-specific Na(+)-dependent inorganic phosphate cotransporter (DNPI) in the rat forebrain.

  2000cited by this paper
• Opioids, reward and addiction: An encounter of biology, psychology, and medicine.

  1999cited by this paper
• Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice.

  1999cited by this paper
• Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception.

  1998cited by this paper
• -Opposing actions of the ?-opioid receptor

  1998cited by this paper
• Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone.

  1998cited by this paper
• Chronic naltrexone differentially affects supraspinal δ-opioid receptor-mediated antinociception

  1998cited by this paper
• mu-Opposing actions of the kappa-opioid receptor.

  1998cited by this paper
• Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain.

  1997cited by this paper
• Quantitative autoradiographic mapping of μ-, δ- and κ-opioid receptors in knockout mice lacking the μ-opioid receptor gene

  1997cited by this paper
• Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene.

  1997cited by this paper
• Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides

  1995cited by this paper
• Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity.

  1995cited by this paper
• Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels.

  1995cited by this paper
• Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment.

  1995cited by this paper
• Effect of chronic exposure to naltrexone and opioid selective agonists on G protein mRNA levels in the rat nervous system.

  1994cited by this paper
• Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.

  1993cited by this paper
• Chronic pretreatment with naltrexone facilitates acquisition of intravenous cocaine self-administration in rats.

  1990cited by this paper
• Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.

  1990cited by this paper
• Chronic opioid antagonist treatment: assessment of receptor upregulation.

  1989cited by this paper
• Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.

  1989cited by this paper
• Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE.

  1988cited by this paper
• Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.

  1988cited by this paper
• Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms.

  1988cited by this paper
• Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.

  1988cited by this paper
• Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine.

  1987cited by this paper
• Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.

  1986cited by this paper
• Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat.

  1986cited by this paper
• Goodman & Gilman's The Pharmacological Basis of Therapeutics

  1985cited by this paper
• Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.

  1985cited by this paper
• Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation.

  1985cited by this paper
• Visualization of opiate receptor upregulation by light microscopy autoradiography.

  1984cited by this paper
• Naltrexone-induced opiate receptor supersensitivity.

  1982cited by this paper
• Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment.

  1982cited by this paper

• Perioperative Naltrexone Management: A Scoping Review by the Perioperative Pain and Addiction Interdisciplinary Network

  2024cites this paper
• Differential temporal decline of cerebral oxytocin and μ‐opioid receptor density during the aging process in mice

  2024cites this paper
• Treatment of Acute Pain in Patients on Naltrexone: A Narrative Review

  2023cites this paper
• Sex-dependent impact of microbiota status on cerebral µ -opioid receptor density in fischer rats

  2023cites this paper
• Sex‐dependent impact of microbiota status on cerebral μ‐opioid receptor density in fischer rats

  2022cites this paper
• Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes

  2020cites this paper
• Interindividual variability and lateralization of μ-opioid receptors in the human brain

  2020cites this paper
• State-of-The-Art Treatment of Opioid Use Disorder

  2019cites this paper
• Morphine-dependent and abstinent mice are characterized by a broader distribution of the neurons co-expressing mu and delta opioid receptors.

  2019cites this paper
• Interindividual variability and lateralization of µ-opioid receptors in the human brain

  2019cites this paper
• Opioid Use Disorders: Perioperative Management of a Special Population

  2018cites this paper
• Naltrexone Maintenance Fails to Alter Amphetamine Effects on Intracranial Self-Stimulation in Rats

  2018cites this paper
• Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors

  2017cites this paper
• Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats

  2017cites this paper
• Rearing environment differentially modulates cocaine self-administration after opioid pretreatment: A behavioral economic analysis.

  2016cites this paper
• Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.

  2016cites this paper
• Naltrexone-facilitated buprenorphine discontinuation: a feasibility trial.

  2015cites this paper
• Fluorescent knock-in mice to decipher the physiopathological role of G protein-coupled receptors

  2015cites this paper
• Challenges in the perioperative management of the patient receiving extended-release naltrexone.

  2014cites this paper
• Targeting opioid receptors with pharmacological chaperones.

  2014cites this paper
• A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks

  2014cites this paper
• The Novel Role of Opioid μ-receptors in Gastroenterology

  2013cites this paper
• Pharmacological traits of delta opioid receptors: pitfalls or opportunities?

  2013cites this paper
• Treatment of opioid dependence

  2013cites this paper
• Fentanyl and Dezocine Associated Application Enhance the Analgesic Effect in Female Patients: A Randomized, Double-blinded, Prospective, Control Study

  2013cites this paper
• UWA Research Publication

  2013cites this paper
• Involvement of the endogenous opioid system in the psychopharmacological actions of ethanol: the role of acetaldehyde

  2013cites this paper
• Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: A PET study using [11C]carfentanil

  2012cites this paper
• Distribution of delta opioid receptor-expressing neurons in the mouse hippocampus.

  2012cites this paper
• Maternally Administered Sustained-Release Naltrexone in Rats Affects Offspring Neurochemistry and Behaviour in Adulthood

  2012cites this paper
• Chronic treatment with the opioid antagonist naltrexone favours the coupling of spinal cord μ-opioid receptors to Gαz protein subunits.

  2012cites this paper
• Naltrexone extended-release injection: an option for the management of opioid abuse

  2011cites this paper
• Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

  2011cites this paper
• Upregulating G Protein-Coupled Receptors with Receptor Antagonists

  2011cites this paper
• Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.

  2010cites this paper
• Effects of Opioid Antagonists on the Abuse-Related Effects of Psychomotor Stimulants and Nicotine

  2009cites this paper
• Chaperone-like effects of cell-permeant ligands on opioid receptors.

  2009cites this paper
• Effects of chronic nicotine on behavioural and neurochemical responses to morphine

  2009cites this paper
• Upregulation of Opioid Receptors

  2009cites this paper
• Reward processing by the opioid system in the brain.

  2009cites this paper
• Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure.

  2008cites this paper
• Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.

  2008cites this paper
• Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone.

  2008cites this paper
• Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.

  2008cites this paper
• Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.

  2008cites this paper
• A Select Set of Opioid Ligands Induce Up-Regulation by Promoting the Maturation and Stability of the Rat κ-Opioid Receptor in Human Embryonic Kidney 293 Cells

  2007cites this paper
• Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

  2007cites this paper
• μ-Opioid Receptor Up-Regulation and Functional Supersensitivity Are Independent of Antagonist Efficacy

  2007cites this paper
• Imaging of opioid receptors in the central nervous system

  2007cites this paper
• Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.

  2007cites this paper
• Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone.

  2006cites this paper
• REVIEW: Modulation of high alcohol drinking in the inbred Fawn–Hooded (FH/Wjd) rat strain: implications for treatment

  2006cites this paper
• Genetic moderators of naltrexone's effects on alcohol cue reactivity.

  2006cites this paper
• Evidence-Based Treatment of Opioid-Dependent Patients

  2006cites this paper
• A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence

  2006cites this paper
• Evidenced-Based Treatment of Opioid-Depend ent Patients

  2006cites this paper
• Ligands Regulate Cell Surface Level of the Human κ Opioid Receptor by Activation-Induced Down-Regulation and Pharmacological Chaperone-Mediated Enhancement: Differential Effects of Nonpeptide and Peptide Agonists

  2006cites this paper
• Food Intake and Reward Mechanisms in Patients with Schizophrenia: Implications for Metabolic Disturbances and Treatment with Second-Generation Antipsychotic Agents

  2006cites this paper
• μ-Opioid Receptors are not Involved in Acute Cocaine-Induced Locomotor Activity nor in Development of Cocaine-Induced Behavioral Sensitization in Mice

  2005cites this paper
• Guideline for Physicians Working in California Opioid Treatment Programs

  2005cites this paper
• Effect of selective antagonism of mu(1)-, mu(1/2)-, mu(3)-, and delta-opioid receptors on the locomotor-stimulating actions of ethanol.

  2005cites this paper
• Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.

  2005cites this paper
• Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.

  2005cites this paper
• Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).

  2005cites this paper
• Clorazepate affects cell surface regulation of delta and kappa opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain.

  2005cites this paper
• Vulnerability for cocaine dependence / Involvement of µ-opioid receptors

  2004cites this paper
• Opposite effects of acute versus chronic naltrexone administration on ethanol-induced locomotion.

  2004cites this paper
• Genetic and pharmacological manipulation of mu opioid receptors in mice reveals a differential effect on behavioral sensitization to cocaine.

  2004cites this paper
• Chronic administration of nalmefene leads to increased food intake and body weight gain in mice.

  2004cites this paper
• A non-invasive gating device for continuous drug delivery that allows control over the timing and duration of spontaneous opiate withdrawal.

  2004cites this paper
• Stress-induced REM sleep increase is antagonized by naltrexone in rats

  2003cites this paper